Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
The EMBO Journal|March 13, 2002
Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activationKrzysztof Masternak, Walter ReithFrontiers in Immunology|November 2, 2023
Extracellular nicotinamide phosphoribosyltransferase: role in disease pathophysiology and as a biomarkerElise Semerena, Alessio Nencioni, Krzysztof MasternakMolecular and Cellular Biology|September 17, 2005
New functions of the major histocompatibility complex class II-specific transcription factor RFXANK revealed by a high-resolution mutagenesis studyMichal Krawczyk, Krzysztof Masternak, Madeleine Zufferey, et al.Nature Immunology|January 14, 2003
Chromatin remodeling and extragenic transcription at the MHC class II locus control regionKrzysztof Masternak, Nicolas Peyraud, Michal Krawczyk, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2004
Long distance control of MHC class II expression by multiple distal enhancers regulated by regulatory factor X complex and CIITAMichal Krawczyk, Nicolas Peyraud, Natalia Rybtsova, et al.The Journal of Biological Chemistry|July 24, 2004
The S box of major histocompatibility complex class II promoters is a key determinant for recruitment of the transcriptional co-activator CIITAAnnick Muhlethaler-Mottet, Michal Krawczyk, Krzysztof Masternak, et al.Immunology|December 18, 2003
In vivo, RFX5 binds differently to the human leucocyte antigen-E, -F, and -G gene promoters and participates in HLA class I protein expression in a cell type-dependent mannerPhilippe Rousseau, Krzysztof Masternak, Michal Krawczyk, et al.Blood|November 6, 2010
CCR7 is involved in the migration of neutrophils to lymph nodesCéline Beauvillain, Pierre Cunin, Andrea Doni, et al.Experimental Hematology & Oncology|May 10, 2022
CD47xCD19 bispecific antibody triggers recruitment and activation of innate immune effector cells in a B-cell lymphoma xenograft modelXavier Chauchet, Laura Cons, Laurence Chatel, et al.Antibodies (Basel, Switzerland)|September 24, 2019
Tumor-Directed Blockade of CD47 with Bispecific Antibodies Induces Adaptive Antitumor ImmunityElie Dheilly, Stefano Majocchi, Valéry Moine, et al.Pageof 2